Skip to main content
Premium Trial:

Request an Annual Quote

Antigen Discovery Nets $3M SBIR Grant

NEW YORK (GenomeWeb News) – Antigen Discovery said last week that it has received a $3 million Phase II Small Business Innovation Research grant to fund further development of its protein microarray-based serodiagnostic platform.
The Irvine, Calif.-based firm said that the platform is being developed for biodefense and emerging infectious disease applications. It will collaborate on the development program with researchers at the proteomics core facility of the Pacific Southwest Regional Center of Excellence at the University of California, Irvine.
“By using our novel protein array systems and statistical algorithms, we can rapidly discover antigen sets that will provide serological tests that discriminate between different infections, or even between different stages of the same infection,” Huw Davies, principal investigator on the grant, said in a statement.
The SBIR grant was awarded by the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.